Cell Therapeutics, Inc. (CTIC) to Present at Upcoming Investor Conferences
5/15/2013 7:07:48 AM
More...
|
Cell Therapeutics, Inc. (CTIC) Reports First Quarter 2013 Financial Results
5/3/2013 6:33:22 AM
More...
|
Cell Therapeutics, Inc. (CTIC) to Report First Quarter Financial Results After Market on May 2, 2013
4/24/2013 6:30:14 AM
More...
|
Cell Therapeutics, Inc. (CTIC) Secures $15 Million Loan Financing Agreement
3/28/2013 7:07:48 AM
More...
|
Cell Therapeutics, Inc. (CTIC) to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
3/11/2013 6:46:43 AM
More...
|
Cell Therapeutics, Inc. (CTIC) Release: German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation Within Early Benefit Assessment Process of PIXUVRI® (pixantrone)
3/4/2013 10:35:55 AM
More...
|
Cell Therapeutics, Inc. (CTIC) Release: Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology
3/4/2013 9:40:23 AM
More...
|
Cell Therapeutics, Inc. (CTIC) Reports Fourth Quarter and Full Year 2012 Financial Results
3/1/2013 7:30:52 AM
More...
|
Cell Therapeutics, Inc. (CTIC) to Report Fourth Quarter and Full Year 2012 Financial Results After Market on February 28, 2013
2/26/2013 6:17:42 AM
More...
|
Cell Therapeutics, Inc. (CTIC) Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
1/31/2013 8:44:11 AM
More...
|
|